|
|
|
|
Conference:
Pre-conference workshop
14 Sept 9am - 5pm
Day 1
15 Sept 8am - 5:30pm
Day 2
16 Sept 8am - 5:30pm
Post-conference workshop
17 Sept 9am - 5pm
Location: London, United Kingdom
› Email a friend
› Add this to my calendar
|
|
|
|
|
Drive your safety strategy forward
The 4th annual World Drug Safety Congress Europe conference brings together top pharmaceutical, biotechnology and regulatory representatives in a forum that addresses the key issues of the industry.
|
For delegates
Health Network Communications would like to announce the 4th annual World Drug Safety Congress 2010, taking place 14 - 17 September in London, United Kingdom.
Making and fulfilling the right safety procedures is vitally important in today’s pharmaceutical industry and imperative to ensuring the successful long term future of a drug. At World Drug Safety Congress Europe you will find yourself amongst industry decision makers and thought leaders in this unique discussion forum.
» Get my quote
» Reserve your seat now
|

Revolutionise your drug safety strategy
|
|
The content
The in-depth drug safety conference programme covers the detection, analysis and prevention of adverse drug reactions with case studies and industry experiences as well as global regulatory coverage of developments in the US, Japan, Europe, Asia/Pacific, South America and Canada.
» More about the conference
|
The speakers
At World Drug Safety Congress Europe you can expect to see speakers from a wide range of countries. There will be case study updates, and we will strive to introduce fresh strategy content as we continue to keep track of the latest developments.
» Become a speaker
|
The people that matter to your business - drug safety professionals
This conference will be attended by directors, heads and managers working in the pharmaceutical industry in the following departments:
|
Pharmacovigilance
Drug Safety
Risk management and surveillance
Qualified person
Medical affairs
Quality specialist
Clinical safety
|
Chief Scientific Officer
Chief Medical Officer
Regulatory Affairs
Research and development
Chief Executive Officer
Managing Director
Drug Manufacturing
|
» Networking opportunities
|
|
|
|
|
|
|
|
|
|